腹膜透析在慢性肾衰竭伴肝硬化腹水中的应用

目的探讨腹膜透析(PD)在慢性肾衰竭伴肝硬化腹水患者中的应用价值。方法 15例慢性肾衰竭伴肝硬化腹水患者,经综合保守治疗或血液透析治疗不能改善临床症状的患者改用PD治疗后,观察患者自觉症状、浮肿及营养体征的改善情况,测定PD治疗前及3个月后血尿素氮(BUN)、血肌酐(Scr)、血红蛋白(Hb)、总蛋白(TP)、白蛋白(Alb)等指标的变化情况。结果患者经PD后自觉症状明显好转,食欲改善,浮肿逐渐消退。BUN、Scr明显下降(P<0.05),Hb明显上升(P<0.05),差异显著。Alb虽略有所提升,但差异无统计学意义(P>0.05)。结论腹膜透析治疗慢性肾衰竭伴肝硬化腹水患者效果显著,是一种有效、简便、安全的治疗方法。

Effects of Peritoneal Dialysis on Chronic Renal Failure with Liver Cirrhosis and Ascites

Objective To investigate the effect of peritoneal dialysis(PD) in the treatment of chronic renal failure patients with liver cirrhosis and ascites.Methods Fifteen chronic renal failure patients with liver cirrhosis and ascites,when their clinical symptoms could not be improved by internal medicine therapy or hemodialysis,underwent the peritoneal dialysis.received but patients unable to,The subjective symptom,edema and nutritional status were observed,and the blood urea nitrogen(BUN),serum creatinine(Scr),hemoglobin(Hb),total protein(TP),albumin(Alb) were determined before PD and 3 months after the treatment.Results After peritoneal dialysis the subjective symptoms of all patients got better obviously,the appetite was improved,the edema disappeared gradually,nutritional status was improved,and BUN and Scr decreased obviously(P<0.05),while Hb increased significantly(P<0.05).Alb was no significant change(P>0.05).Conclusion Peritoneal dialysis is an effective,safe,simple treatment method for the chronic renal failure patients with liver cirrhosis and ascites.